Foundry Silica Sand: AFS Grain Fineness, Specifications and Uses

Published: Source: Silica Raw Materials News Section: Silica Raw Materials

📌 Key Takeaways

  • Topic: HDK N20: Specifications, Applications and Equivalent Grades
  • Keywords: silica aerogel blanket
  • Published: 2026-11-20 02:30:43
  • Field: Silica (SiO₂) raw materials · Inorganic non-metallic materials · Chemicals
This supports that the release rate depends on several components, among others, influenced by the pore size, the pore structure, the amount of drug loaded, the solubility of the API, and the resulting interaction between the carrier and the transported molecules [ 2 ]. By modifying these, the release kinetics can be controlled to a small extent, but a considerable influence can only be attained by surface functionalization of the mesopores. The following table contains some experimental data in terms of drug release in case of the previously shown APIs ( Table 2 ).

Best Thixotropic Agent for Epoxy: How Fumed Silica Prevents Sagging

Silica as a Toothpaste Abrasive: How It Cleans and How RDA Is Controlled
22. Tahir H., Shahzad Y., Waters L.J., Hussain T., Yousaf A.M., Mahmood T., Sheikh R. Impact of processing methods on the dissolution of artemether from two non-ordered mesoporous silicas. Eur. J. Pharm. Sci. 2018;112:139-145. doi: 10.1016/j.ejps.2017.11.016. [ DOI ] [ PubMed ] [ Google Scholar ]
INS 551 Explained: Silicon Dioxide Food Additive Code, Uses and Regulations
Experiments with different dosage forms and their potential use in treatment.
Monocrystalline Silicon vs Silica: How Silicon Wafers Are Made from Quartz
The immune activation through functional nanocarriers is realized by interactions with innate immune cells such as macrophages, neutrophils, and complement proteins. Immune recognition triggers inflammation, immune responses, or even swift clearance, thus presumably constraining therapeutic effects. Surface properties, such as chemical composition, topography, and charge, may influence the immune cell activation and binding specificity. The possible immune interactions need to be well characterized for the development of stealth and immunocompatible nanoparticles [ 82 ]. Immune-derived side influences, such as cytokine release and complement activation, potentially corrupt the safety and the effectiveness of drug delivery [ 80 ]. Other problems that may affect nanoparticle penetration and the effectiveness of targeting are the heterogeneity of the target tissue and tumor microenvironment. Problems of stability, biodegradation rates, and nanoparticle agglomeration may also affect the effectiveness of action [ 80 ].
Silicon Dioxide Side Effects: What You Need to Know

Silica for Chromatography: Particle Size, Pore Size and Grade Selection

What is silica (SiO₂)?

hydrophobic fumed silica Targeted therapy, aiming, for instance, at antitumor treatments, can be divided into active and passive forms [ 72, 73 ]. Passive targeting is based on higher vascularity and higher vascular permeability of the tumor, as well as inflamed tissues, compared to physiological ones [ 73, 74 ]. Additionally, the lymphatic circulation of the tumor shows decreased efficiency [ 25 ], which led to easier accumulation of nanoparticles in the tumor or inflamed tissues [ 10, 27, 72, 74 ]. This passive accumulation is normally called "ELVIS" (Extravasation through Leaky Vasculature and later Inflammatory cell-mediated Sequestration) [ 72, 74 ]. From the facet of surface qualities, negatively charged nanoparticles accumulate less effectively inside cells, due to the negatively charged cell membrane, which slows down the cellular uptake, so, in this case, a neutral surface charge is more favorable [ 25 ]. In contrast, active targeting can be accomplished by functionalizing the outer surface of the silica carriers [ 10, 27, 72 ], where molecules are attached to the surface of the carriers that specifically bind to certain cell surface ligands and receptors, which are characteristic of tumor-, but not of healthy cells. This selective method provides more effective treatment and reduces the side impacts of cytotoxic APIs on healthy cells and tissues [ 10, 27 ]. The most recent findings on active targeting possibilities are summarized in Table 3. García-Fernández et al. prepared a mesoporous silica-based nanocarrier loaded with dexamethasone and capped with a particular protein to actively target the TNFR1 receptor, which is overexpressed in pro-inflammatory macrophages [ 72 ]. Since the carriers are preferably internalized by these macrophages, the cargo is released in a controlled manner, during enzymatic hydrolysis, thus preventing premature drug release, thanks to the gatekeepers. The targeting talent was tested in vitro with activated macrophages. On the other hand, the therapeutic efficiency was tested in vivo in mouse models. The researchers observed greater therapeutic impacts and fewer adverse side influences than in the case of free dexamethasone. To sum up, dexamethasone-loaded MSN has been effectively developed to actively target the lungs in acute lung injury (ALI), and this result may also be promising in other lung diseases (COPD, asthma) [ 72 ]. Teruel et al. presented a novel approach in oral inflammatory bowel sickness (IBD) therapy, using functionalized magnetic mesoporous silica microparticles [ 75 ].

What is the difference between fumed silica and precipitated silica?

silica for coatings 7.2. Granules/Pellets

What drives silica raw material prices?

Cab-O-Sil alternative Mathematical modeling, particularly the application of the Fick diffusion equation, is really beneficial in clarifying and predicting drug release from polymeric or porous matrices. Fick's laws describe diffusion as the movement of molecules from a greatly concentrated region to a region where the concentration is lower. Fick's first law presumes the diffusion flux to be directly proportional to the concentration gradient. Fick's second law controls the spatial and temporal change in concentration in the release medium [ 59 ]. For drug release, the general equation is as follows (Equation (3)).

Cite this article: Silica Raw Materials News. "Novoray: Company Overview, Spherical Silica Products and Applications ." Published 2026-11-20 02:30:43. /news/article.html
Disclaimer: Prices and data are for reference only and do not constitute purchasing or investment advice. Please credit the source when republishing.